The agency hasn’t previously been able to track medical device shortages, as devicemakers aren’t required to report shortages the way drugmakers are.
But a section of the Coronavirus Aid, Relief and Economic Security Act, or CARES Act, requires manufacturers to tell the FDA of any interruptions in the supply chain of medical devices that are likely to affect U.S. hospitals’ ability to treat COVID-19 patients.
The rule will only be in effect while the pandemic is considered a public health emergency in the U.S., according to the FDA.
Read the full news release here.
More articles on supply chain:
ICE working with Amazon, Pfizer to keep fake COVID-19 supplies out of US
FDA tightens standards for COVID-19 antibody tests
LabCorp furloughs employees
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
